推进卵子冷冻技术临床应用的若干思考  

Perspectives about promoting the application of the oocyte cryopreservation

作　　者：马艺[1] 白符[1] 刘畅[1] 樊延军[1] 

机构地区：[1]中国疾病预防控制中心妇幼保健中心,北京100050

出　　处：《中华生殖与避孕杂志》2017年第8期667-670,共4页Chinese Journal of Reproduction and Contraception

摘　　要：目的分析卵子冷冻技术在我国的社会需求、临床应用的可行性及可能给管理带来的主要问题,提出政策建议。方法检索国内外卵子冷冻技术相关文献,梳理国内外辅助生殖技术(ART)管理相关政策。结果利用玻璃化冷冻卵子进行体外受精-胚胎移植(IVF-ET)治疗的效果与新鲜卵子接近。我国卵子冷冻技术主要应用于取卵日男方取精失败的应急性冷冻卵子。卵子冷冻技术的短期风险较低,其应用具有临床意义和社会意义。社会因素冷冻卵子虽然伦理争议较多,但是存在一定的需求。结论适时启动卵子冷冻技术临床应用的相关政策研究,审慎开展临床试点,科学进行舆论引导,不断加强技术评估。Objective To analyze the feasibility and necessity of the application of oocyte cryopreservation technology in China, and to give some suggestions to the management. Methods Domestic and international literatures on oocyte cryopreservation technology were searched. The domestic and international policy of assisted reproductive technology （ART） administration were reviewed. Results In vitro fertilization （IVF） with vitrified oocytes achieved similar outcomes to IVF using fresh oocytes. In our country, the egg freezing technology is mainly applied to the patients whose husbands fail to provide sperm samples at the time of oocyte pickup. Part of the centers has achieved reasonable outcomes. The short-term risk of egg freezing technology is relatively low, and its application has clinical validity and social significance. Although there are many theoretical debates surrounding oocyte cryopreservation for non-medical reasons, there are real needs. Conclusion It is necessary to timely launch policy research on oocyte cryopreservation, carefully proceed clinical trial, scientifically guide public opinion and constantly strengthen the technical assessment.

关 键 词：卵子冷冻 社会因素卵子冷冻 管理 政策建议 

分 类 号：R714.8[医药卫生—妇产科学]